{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:51:14Z","timestamp":1793371874589,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3404104"],"award-info":[{"award-number":["2023YFC3404104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230097"],"award-info":[{"award-number":["82230097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273128"],"award-info":[{"award-number":["82273128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118571","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:56:11Z","timestamp":1767945371000},"page":"118571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects"],"prefix":"10.1016","volume":"306","author":[{"given":"Tianyang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8101-6159","authenticated-orcid":false,"given":"Yanlin","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-8722","authenticated-orcid":false,"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118571_bib1","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118571_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/jacs.2c10177","article-title":"Radiotherapy-triggered proteolysis targeting chimera prodrug activation in tumors","volume":"145","author":"Yang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118571_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.jmedchem.8b01631","article-title":"Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer","volume":"62","author":"Han","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.118571_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13046-020-01672-1","article-title":"Proteolysis targeting chimeras (PROTACs) in cancer therapy","volume":"39","author":"Oca\u00f1a","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118571_bib6","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1038\/s41388-020-1336-y","article-title":"PROteolysis TArgeting chimeras (PROTACs) as emerging anticancer therapeutics","volume":"39","author":"Khan","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.118571_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112539","article-title":"PROTAC: a promising technology for cancer treatment","volume":"203","author":"Zhou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.118571_bib9","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1016\/j.apsb.2025.07.020","article-title":"Photodynamic enhancement of PROTAC prodrug activation in hypoxic tumors","volume":"15","author":"Fu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118571_bib10","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1002\/anie.201813648","article-title":"Release of amino\u2010 or carboxy\u2010containing compounds triggered by HOCl: application for imaging and drug design","volume":"58","author":"Wei","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib11","article-title":"A smart theranostic prodrug system activated by reactive oxygen species for regional chemotherapy of metastatic cancer","volume":"61","author":"Liu","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1039\/C7SC03784H","article-title":"Deformylation reaction-based probe for in vivo imaging of HOCl","volume":"9","author":"Wei","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.118571_bib13","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1039\/D1CC05715D","article-title":"Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia","volume":"57","author":"Cheng","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118571_bib14","article-title":"Light-induced control of protein destruction by opto-PROTAC","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.118571_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay5064","article-title":"PHOTACs enable optical control of protein degradation","volume":"6","author":"Reynders","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.118571_bib16","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1021\/jacs.9b06422","article-title":"Light-induced protein degradation with photocaged PROTACs","volume":"141","author":"Xue","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118571_bib17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/jacs.9b12718","article-title":"Optical control of small molecule-induced protein degradation","volume":"142","author":"Naro","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118571_bib18","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/jacs.1c00451","article-title":"Cancer selective target degradation by folate-caged PROTACs","volume":"143","author":"Liu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118571_bib19","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1038\/s41467-024-50735-w","article-title":"A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118571_bib20","doi-asserted-by":"crossref","first-page":"14155","DOI":"10.1021\/jacs.3c05159","article-title":"Bioorthogonal PROTAC prodrugs enabled by on-target activation","volume":"145","author":"Chang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118571_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202306824","article-title":"Stimuli\u2010responsive PROTACs for controlled protein degradation","volume":"62","author":"An","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/acscentsci.6b00280","article-title":"Protein degradation by in-cell self-assembly of proteolysis targeting chimeras","volume":"2","author":"Lebraud","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2026.118571_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202315425","article-title":"Senolysis enabled by senescent cell\u2010sensitive bioorthogonal tetrazine ligation","volume":"63","author":"Chang","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib24","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1021\/jacs.5c04857","article-title":"Reactive oxygen species-instructed supramolecular assemblies enable bioorthogonally activatable protein degradation for pancreatic cancer","volume":"147","author":"Yao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118571_bib27","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1016\/j.apsb.2025.06.028","article-title":"Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy","volume":"15","author":"Jang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118571_bib29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/acscentsci.9b00713","article-title":"Reversible spatiotemporal control of induced protein degradation by bistable PhotoPROTACs","volume":"5","author":"Pfaff","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2026.118571_bib32","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/acs.jmedchem.1c02221","article-title":"Rational design for nitroreductase (NTR)-responsive proteolysis targeting chimeras (PROTACs) selectively targeting tumor tissues","volume":"65","author":"Shi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117237","article-title":"Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands","volume":"82","author":"Cheng","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib35","article-title":"Self\u2010oxygenating PROTAC microneedle for spatiotemporally\u2010confined protein degradation and enhanced glioblastoma therapy","volume":"37","author":"Jiang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2026.118571_bib36","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1021\/acs.nanolett.4c02287","article-title":"Ultrasound-activated PROTAC prodrugs overcome immunosuppression to actuate efficient deep-tissue sono-immunotherapy in orthotopic pancreatic tumor mouse models","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejmech.2026.118571_bib37","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1039\/D2CC03367D","article-title":"Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation","volume":"58","author":"Liu","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118571_bib38","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.31635\/ccschem.022.202101529","article-title":"Enzyme-catalyzed activation of Pro-PROTAC for cell-selective protein degradation","volume":"4","author":"Liang","year":"2022","journal-title":"CCS Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib39","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1038\/s41467-022-32050-4","article-title":"Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118571_bib40","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/acs.jmedchem.0c01846","article-title":"Antibody-mediated delivery of chimeric brd4 degraders. Part 2: improvement of in vitro antiproliferation activity and in vivo antitumor efficacy","volume":"64","author":"Dragovich","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib41","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/acs.jmedchem.0c01845","article-title":"Antibody-mediated delivery of chimeric brd4 degraders. Part 1: exploration of antibody linker, payload loading, and payload molecular properties","volume":"64","author":"Dragovich","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/acschembio.0c00285","article-title":"Antibody\u2013PROTAC conjugates enable her2-dependent targeted protein degradation of BRD4","volume":"15","author":"Maneiro","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118571_bib43","doi-asserted-by":"crossref","first-page":"23299","DOI":"10.1002\/anie.202107347","article-title":"Aptamer\u2010PROTAC conjugates (APCs) for tumor\u2010specific targeting in breast cancer","volume":"60","author":"He","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib44","article-title":"Smart Nano\u2010PROTACs reprogram tumor microenvironment for activatable photo\u2010metabolic cancer immunotherapy","volume":"61","author":"Zhang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib45","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-021-23194-w","article-title":"Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118571_bib46","article-title":"Checkpoint Nano\u2010PROTACs for activatable cancer photo\u2010immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2026.118571_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118485","article-title":"Exogenous\/endogenous stimuli-responsive antitumor prodrugs advance precision chemotherapy","volume":"132","author":"Wang","year":"2026","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118571_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/2394-8108.178548","article-title":"Methylene blue treatment in experimental ischemic stroke: a mini-review","volume":"2","author":"Jiang","year":"2016","journal-title":"Brain Circ."},{"key":"10.1016\/j.ejmech.2026.118571_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.12.012","article-title":"\u201cLest we forget you \u2014 methylene blue \u2026,\u201d","volume":"32","author":"Schirmer","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2026.118571_bib50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00464-007-9463-x","article-title":"The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma","volume":"22","author":"Ormeci","year":"2008","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.ejmech.2026.118571_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1572-1000(05)00097-9","article-title":"Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications","volume":"2","author":"Tardivo","year":"2005","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.ejmech.2026.118571_bib52","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1039\/C5CC03824C","article-title":"Nitroreductase-triggered activation of a novel caged fluorescent probe obtained from methylene blue","volume":"51","author":"Bae","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118571_bib53","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.coph.2010.05.003","article-title":"Redox metabolism and malignancy","volume":"10","author":"Grek","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118571_bib54","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.biomac.9b01578","article-title":"Glutathione and reactive oxygen species dual-responsive block copolymer prodrugs for boosting tumor site-specific drug release and enhanced antitumor efficacy","volume":"21","author":"Yin","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2026.118571_bib55","article-title":"PROTAC prodrug-integrated nanosensitizer for potentiating radiation therapy of cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2026.118571_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202510641","article-title":"Tandem\u2010activatable PROTAC prodrug for tumor biomarker\u2010driven near\u2010infrared opto\u2010proteolysis","volume":"64","author":"Lu","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118571_bib60","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2023.07.062","article-title":"Targeted delivery of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted cancer therapy","volume":"361","author":"Huang","year":"2023","journal-title":"J. Contr. Release"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:30:53Z","timestamp":1773973853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"alternative-id":["S0223523426000164"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118571","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-stimuli activated PROTAC prodrug for controlled protein degradation with enhanced therapeutic effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118571"}}